Previsioni di mercato dei radiofarmaci in Medio Oriente e Africa fino al 2028 – Impatto del COVID-19 e analisi regionale per tipologia (medicina nucleare diagnostica e medicina nucleare terapeutica), applicazione (oncologia, cardiologia, neurologia e altre) e utente finale (ospedali, centri di imaging, Centri accademici e di ricerca e altri)

Introduzione al mercato

Il mercato dei radiofarmaci MEA viene analizzato sulla base dell\'Arabia Saudita, degli Emirati Arabi Uniti, del Sud Africa e del resto del MEA. L’Arabia Saudita è uno dei mercati più grandi della regione. La prevalenza dell’ictus è aumentata in modo significativo nel Regno dell’Arabia Saudita (KSA), diventando un’importante causa di malattie e decessi in Arabia Saudita. Tuttavia, la ricerca riguardante l’incidenza, la prevalenza e le proprietà socio-demografiche dell’ictus è ancora inadeguata rispetto a quella dei paesi sviluppati. Si prevede che la mancanza di consapevolezza sia dovuta alla mancanza di studi adeguati condotti in queste aree specifiche. L’ictus è un problema in rapida crescita in Arabia Saudita ed è una delle principali cause di malattia e morte. Tuttavia, rispetto ai paesi sviluppati, la ricerca sull’incidenza, sulla prevalenza e sulle caratteristiche socio-demografiche dell’ictus è ancora carente a causa della mancanza di studi adeguati in queste aree. Tra gli arabi, una grande percentuale dei fattori di rischio di ictus sono fattori modificabili ben noti come l’ipertensione e il diabete. Il rischio di morire di ictus aumenta con l\'età e il rischio di morire di emorragia cerebrale è più elevato. L\'ictus giovanile rappresenta il 6-20% di tutti gli ictus. A causa delle crescenti strutture legate ai radiofarmaci e della crescente prevalenza di malattie croniche, si prevede che il mercato dei radiofarmaci nella regione MEA assisterà a una crescita significativa durante il periodo di previsione.

In caso di COVID-19, MEA è fortemente colpita soprattutto il Sudafrica. Anche i paesi del Medio Oriente hanno ampiamente influenzato la condizione socioeconomica a causa della pandemia di COVID-19. Tuttavia, i paesi hanno reagito saggiamente alla pandemia di COVID-19 per evitare la diffusione dell’infezione. Come in altre regioni, sono stati imposti il lockdown e il distanziamento sociale, compromettendo queste tendenze e ostacolando l’accesso al lavoro, al reddito regolare, ai pagamenti, alle fiere, alle scuole e all’assistenza sanitaria. Pertanto, si prevede che i paesi abbiano subito enormi perdite e stiano ancora cercando di recuperarle. Il blocco ha ampiamente colpito i servizi medici non di emergenza nella regione, colpendo i dispositivi medici. Paesi come l’Arabia Saudita e gli Emirati Arabi Uniti stanno emergendo come destinazioni sanitarie nelle regioni. Tuttavia, dipendono dai paesi per le risorse. Si prevede che la disponibilità di vaccini e di altre strutture sanitarie nei paesi in via di sviluppo della regione offrirà spazio al mercato per alcuni anni. La pandemia di COVID-19 ha aiutato i paesi sopra menzionati a migliorare le proprie capacità e a mostrare le proprie capacità per quanto riguarda i servizi sanitari. In Arabia Saudita il numero di visite per disturbi neurologici comuni è diminuito del 24%. Rispetto al periodo pre-pandemia, durante tutto il periodo pandemico. L’esempio più notevole sono le scansioni TC cerebrali, che durante il periodo dell’epidemia sono aumentate dell’11,3%. Una delle cause principali della diminuzione delle visite al pronto soccorso è la paura di contrarre l’infezione da COVID-19 semplicemente visitando gli ospedali. È probabile che questi fattori abbiano un impatto negativo sulla crescita del mercato.

Panoramica e dinamiche del mercato

Si prevede che il mercato dei radiofarmaci MEA crescerà da 381,20 milioni di dollari nel 2021 a 639,78 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 7,7% dal 2021 al 2028. L\'uso delle procedure di medicina nucleare si sta espandendo rapidamente, poiché PET e SPECT continuano a migliorare l\'accuratezza del rilevamento, della localizzazione e della caratterizzazione della malattia. PET e SPECT sono tra le modalità radiologiche di medicina nucleare impiegate in contesti clinici. Secondo la Società di Medicina Nucleare, ogni anno milioni di procedure di medicina nucleare vengono eseguite con radiofarmaci e strumenti di imaging per diagnosticare malattie e fornire trattamenti mirati nei paesi della regione. Queste tecniche sono state adottate anche in immunologia, infezioni, gastroenterologia, cardiologia, oncologia, neurologia e psichiatria, tra gli altri campi, per la diagnosi e altre applicazioni. La medicina nucleare avanzata e le moderne apparecchiature di imaging aiutano i medici a diagnosticare le malattie in modo migliore e in meno tempo. Il continuo sviluppo di nuovi radiofarmaci per le piattaforme PET/CT e SPECT/CT, che vengono utilizzati in nuove applicazioni cliniche come la neurologia e l’ortopedia, insieme alla crescente accuratezza dei diversi metodi di stadiazione del tumore, stanno ulteriormente contribuendo alla crescita del mercato. Nel settembre 2020, Curium ha lanciato Detectnet, un agente per tomografia a emissione di positroni (PET), indicato per la localizzazione di tumori neuroendocrini (NET) positivi al recettore della somatostatina in pazienti adulti. Pertanto, i progressi tecnologici per migliorare la qualità e l\'efficacia delle tecniche di imaging nucleare stanno favorendo la crescita del mercato dei radiofarmaci MEA.

Segmenti chiave del mercato

In termini di tipologia, il segmento della medicina nucleare diagnostica ha rappresentato la quota maggiore del mercato dei radiofarmaci MEA nel 2020. In termini di applicazione, il segmento oncologico ha detenuto una quota di mercato maggiore del mercato dei radiofarmaci MEA nel 2020. Inoltre, nel 2020 il segmento ospedaliero deteneva una quota maggiore del mercato dei radiofarmaci MEA in base all\'utente finale.

Principali fonti e aziende elencate

Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato dei radiofarmaci MEA sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono Advanced Accelerator Applications, Bayer AG, Bracco Imaging SpA, Cardinal Health Inc, Curium, ECZACIBA?I MONROL NUCLEAR PRODUCTS CO., GENERAL ELECTRIC, Nordion e NTP RADIOISOTOPES.

Rapporto sui motivi per acquistare

Comprendere il panorama del mercato dei radiofarmaci MEA e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte ritorno
Mantenere un vantaggio comprendendo il panorama competitivo in continua evoluzione per il mercato dei radiofarmaci MEA
Pianificare in modo efficiente operazioni di fusione e acquisizione e accordi di partnership nel mercato dei radiofarmaci MEA identificando i segmenti di mercato con le vendite probabili più promettenti
Aiuta a prendere decisioni aziendali consapevoli grazie a un\'analisi perspicace e completa delle prestazioni di mercato dei vari segmenti dal mercato dei radiofarmaci MEA
Ottenere previsioni sui ricavi di mercato per vari segmenti dal 2021 al 2028 nella regione MEA.

Segmentazione del mercato dei radiofarmaci MEA

Mercato dei radiofarmaci MEA - Per tipo

Medicina nucleare diagnostica
- SPECT
- PET
Medicina nucleare terapeutica
- Emettitori alfa
- Emettitori beta
- Isotopi della brachiterapia

< p>Mercato dei radiofarmaci MEA - per applicazione

Oncologia
Cardiologia
Neurologia
Altro

Mercato dei radiofarmaci MEA - Per utente finale

Ospedali
Centri di imaging
Centri accademici e di ricerca ;
Altri

Mercato dei radiofarmaci MEA: per paese

Arabia Saudita
Sudafrica
Emirati Arabi Uniti
Resto del MEA

Mercato dei radiofarmaci MEA - Profili aziendali

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Radiopharmaceuticals Market – By Type

1.3.2 MEA Radiopharmaceuticals Market – By Application

1.3.3 MEA Radiopharmaceuticals Market – By End User

1.3.4 MEA Radiopharmaceuticals Market– By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Radiopharmaceuticals Market– Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Experts Opinion

5. MEA Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Escalation in the Usage of Alpha Radio Immunotherapy

5.1.2 Surging Advancements in Nuclear Imaging Techniques

5.2 Market Restraints

5.2.1 Accessibility of Substitutes

5.3 Market Opportunities

5.3.1 Growth Potential in Several Countries

5.4 Future Trends

5.4.1 Burgeoning Usage of Nuclear Medicines for Personalized Treatment

5.5 Impact Analysis

6. Radiopharmaceuticals Market– MEA Analysis

6.1 MEA Radiopharmaceuticals Market Revenue Forecast and Analysis

7. MEA Radiopharmaceuticals Market Analysis – By Type

7.1 Overview

7.2 MEA Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Nuclear Medicine

7.3.1 Overview

7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 SPECT

7.3.3.1 Overview

7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 PET

7.3.4.1 Overview

7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapeutic Nuclear Medicine

7.4.1 Overview

7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Alpha Emitters

7.4.3.1 Overview

7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Beta Emitters

7.4.4.1 Overview

7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Brachytherapy Isotopes

7.4.5.1 Overview

7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8. MEA Radiopharmaceuticals Market Analysis – By Application

8.1 Overview

8.2 MEA Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cardiology

8.4.1 Overview

8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology

8.5.1 Overview

8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. MEA Radiopharmaceuticals Market Analysis – By End User

9.1 Overview

9.2 MEA Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Imaging Centres

9.4.1 Overview

9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Centers

9.5.1 Overview

9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. MEA Radiopharmaceuticals Market – Country Analysis

10.1 MEA: Radiopharmaceuticals Market

10.1.1 Overview

10.1.2 MEA: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2 Saudi Arabia Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1 Saudi Arabia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2 Saudi Arabia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3 Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4 Saudi Arabia Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.2 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2 UAE Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1 UAE: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2 UAE a: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3 UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4 UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2 South Africa Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1 South Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2 South Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3 South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4 South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.4 Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1 Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2 Rest of MEA Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2.1 Rest of MEA: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.2.2 Rest of MEA: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.3 Rest of MEA Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4 Rest of MEA Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic on MEA Radiopharmaceuticals Market

11.1 MEA: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Inorganic Growth Strategies

12.2.1 Overview

12.3 Organic Growth Strategies

12.3.1 Overview

13. Company Profiles

13.1 Cardinal Health Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Curium

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GENERAL ELECTRIC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Bayer AG

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bracco Imaging S.p.A

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Nordion

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 NTP RADIOISOTOPES

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Advanced Accelerator Applications

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. MEA Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2. Saudi Arabia Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3. Saudi Arabia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4. Saudi Arabia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5. Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 6. Saudi Arabia Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7. UAE Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8. UAE Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9. UAE Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10. UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11. UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. South Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 13. South Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14. South Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15. South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 16. South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of MEA Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of MEA Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19. Rest of MEA Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20. Rest of MEA Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of MEA Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 22. Recent Inorganic Growth Strategies

Table 23. Recent Organic Growth Strategies

Table 24. Glossary of Terms

LIST OF FIGURES

Figure 1. MEA Radiopharmaceuticals Market Segmentation

Figure 2. MEA Radiopharmaceuticals Market Segmentation, By Country

Figure 3. MEA Radiopharmaceuticals Market Overview

Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period

Figure 6. MEA PEST Analysis

Figure 7. MEA Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8. MEA Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9. MEA Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10. MEA Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. MEA SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. MEA PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. MEA Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. MEA Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. MEA Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. MEA Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. MEA Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18. MEA Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. MEA Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. MEA Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. MEA Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. MEA Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23. MEA Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. MEA Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. MEA Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. MEA Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. MEA: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. MEA: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29. Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30. UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32. Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33. Impact of COVID-19 Pandemic in MEA Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA radiopharmaceuticals market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample